Pfizer’s Antiviral Pill Will Be Sold to Dozens of Poor Nations at a DiscountBy Radiant Health
Published: November 21, 2021
Pfizer will allow its oral antiviral medication for Covid-19 to be sold at lower prices in 95 developing countries around the world. Last month, Merck instituted a similar compromise with 105 poorer nations. The two deals mean that more than half of the world’s population will be able to access the life-saving drugs for a discounted rate. However, there are concerns that both China and Russia, with a combined population of 1.5 billion people, are not included in either agreement. Brazil, which had an incredibly high death toll, was also left out.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022
- FDA Bans Juul’s E-Cigarettes and Cartridges - June 27, 2022
- Polio Virus Found in London Sewage - June 27, 2022
- 200 Million Americans Are Drinking Contaminated Water - June 19, 2022
- Young Kids Can Finally Get Vaccinated Against COVID-19 - June 19, 2022
- New Regulations for Baby Sleep Products - June 19, 2022
- FDA Approves First Drug for Alopecia Hair Loss - June 19, 2022
- Personal Use of Hard Drugs Decriminalized in British Columbia - June 6, 2022
- Woman Receives a Brand New Type of Ear Transplant - June 6, 2022
- Children 6 Months and Older are Eligible for Pfizer’s COVID Vaccine - June 6, 2022